Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I think everyone here just wants a level playing field. With respect to changes being made in midtrials and some trials cherry picking who they will allow in their trials, this gets the blood boiling. Safety is the most sought after component in all trials first. Who cares about efficacy if side affects are horrendous. Thus the cure worse than the disease. We have to be patient and I know it sucks, but good things come to those who wait. Every major player is touting their drug and media is gobbling it up and it’s frustrating to hear that we have a winner that is safe and in time will be as effective as the drs. say. If you understand the way things are being fast tracked and vaccinations are being mass produced even b4 trials are past 1st stage, it should present a lot of fear for those willing to get vaccinated. Slow and steady wins the race. In the interim let’s keep a level head and know that the science don’t lie. Leronlimab will prove it.
Shorts are never gone. Just like fleas on a dog.
The Johnny Blue and Cubans are waiting to be enjoyed after huge PR dropping in two days. By Friday there will be celebrations by all CYDY shareholders.
3 big press releases this week IMO. First type A meeting with FDA . Second safety monitoring board recommendation. Third EAU for Leronlimab based on fab results S/C trial. And I forgot the biggest one. President Donald J. Trumps press conference with Cytodyn leadership at the White House. GLTA
Just a little comparison as far as hits are concerned TLSA just submitted a patent application for a potentially nasally administered and orally taken Foralumab for Covid. Stock up big and has been running strong and by the end of the day lost 48% of value. Sounds like Leronlimab waiting on BLA and results and bang shorts hit stock hard. Let’s hit higher lows and get solid foundation before we start rolling again.
Let’s recap. We have a new penicillin called Leronlimab. We are in two trials which within a few days to a couple of weeks can change the world. That is some pretty heavy stuff to digest. I’m sure with Covid 19 not going anywhere soon, there will be the need for our drug. Let’s look past all the negativity and start posting the positive attributes to what can happen real soon. Bitching and moaning is good for stress relief but doesn’t help when we knock the players trying to get things done. It is a process. Normally unblinding can take 6-8 weeks we want it done within 24 hours. It’s not gonna happen. Our CEO is tremendously anxious as well as the many others to get results as fast as possible. But like good whiskey it’s better aged. The door will get knocked on as soon as results come in. Question is can we be patient enough to wait for the knock. In very little time everyone will be looking to break the door down. If you believe that past results of EIND’s and Dr BP and JL and others we have lightning in a bottle. Sounds positive to me. Get more shares if you can because once results are out, there will be no stopping the share price. GLTA
This will stay right under 10% short thresholds so they can short opening on Monday. Before huge news p.r. drop after hours on Monday. All indications is safety committee and FDA type A meeting released.
I for one am very satisfied with the trinkets CytoDyn is selling. Shares of a wonderful stock with huge upside potential. Next week we have numerous catalysts to bolster SP. Hang on to those shares And you will be rewarded many times over.
Sure 15 posts here one week 250 k shares short. I think not. Longs here know who is real and who is not. Nobody buying your story only the science and fantastic results. Patience and time are on our side but unfortunately not for those that are dying unnecessarily because that’s the way trials go. Let’s hope safety committee convened quickly with positive news, trial stopped and placebo replaced with new saving drug and SOC Leronlimab.
Let’s see how shorts twist the 8k when it is filed. Also one nice press release on Monday night or Tuesday morning with safety board recommendation and Type A meeting with FDA . Need a strong news week leading up to results. Positive news will weaken Adam & cronies from bs hit pieces
IMO I think we ride along waiting on news. End of August could fill in around $7. There will be swings in the meantime but when September rolls in which most likely will be the real timeline for uplist, I have a strong feeling that all the variables will congeal. Stock price should climb very positively in September looking at a run between $13-18
Yes as my prior post yesterday nailed it. Three weeks to uplist. No results til end of next week which is extended to hopefully only 10 days. No S/C analysis til end of August. Not enough patients to meet 50% at 195. EAU not until September at earliest. M2M probably extended for phase 3 trial. Delay delay delay BP don’t want this gem to be realized. Offers will come in once M2M results announced. Then big guessing game as to which one of BP really wants Leronlimab in its pipeline and how much are they willing to pay. IMO of course
Reasonable timelines 3 weeks to uplist. End of next week for all results except S/C which will be end of August. More patients needed for better outcomes of trial. Decision for EAU beginning of September. Nader timeline will be Monday. And then it will pass and shorts will drop SP. iMO
Thanks hopester. I believe there is a ton of resistance in the area you speak of. Just because those are the terms of the lender and we see conversion at $10 doesn’t mean anything in the short term without results coming in and being exceptional. M2M results could be really good and FDA may say let’s do a larger phase 3 study. Also it was said there were a lot of deaths in S/C trials. The wild card is assuming that the FDA is going to fast track this drug when OP Warp Speed has given so much $ to big pharma and are more interested in a vaccine than our drug.
Results will not be in tomorrow. Nothing about borrowing money is good. Would be much better off with an FDA approval and sales. The light bill just got more expensive that’s all. It costs money to do business and that is a lot of interest real fast if they blow the CC just like with splitting safety and efficacy. Gives the naysayers ammo to fire many bullets w/o having to try too hard
When results prove to be great, let’s see if those billion dollars investors that are waiting for readout come to play with us. Hoping all the stars align and the world can get a glimpse of hope that Leronlimab will bring to all. Vaccine or not with all the positives that DrBP and others have explained there will come a day for those with Covid to be therapeutically treated in some shape or form with Leronlimab.
Biggest obstacle I see is not the drug but being on the otc. Not much love being thrown our way. Plenty of news and $$$ being thrown around for subpar merchandise. Poor suffering people deserve better. Let’s hope they are rewarded with Emergency Approval from FDA after stellar results.
Yea sorry I sold all my stock too. Can’t provide a link either lol
Cydy reminds me of a poker tournament and IM ALL IN
So the runway for the takeoff ?? needed about ?? more yards to get the plane off the ground to ensure proper liftoff to Nasdaq. Nothing wrong with a little forward planning to build up the war chest heading into the flight to paradise. Many catalyst in the pipeline and with the excite NYPD Evan and Paul this flight will have enough fuel to take us worldwide. Fasten those seatbelts, no more coach. Soon we will be riding in first class
Welcome new investor.
Look for results to come out right as safety interim analysis is done. Two for one as trial is stopped and placebo patients are given LL and FDA gives approval
DD more like basherland.
Past week slams were a gift. Thanks to shorts and all that Nonexistent Dallas contrAct that was disproven this baby has gotten legs real fast. Expect a small profit take b4 close lock in $$$. More big news on contracts signed by end of week. Great job Evan
Many new clients purchasing platform just being rolled out. Revenue streams greatly increasing with new and increased sales force. Multiple purposes including retail, telemedicine, business conferences, and schools intergrated with current other platforms. Rocket fuel added to the spaceship ?, all systems go ?, uplist to Nasdaq coming soon ? we have liftoff.
Amazing growth in the days and months ahead. Badgers still trying to bash 40% revenue increase
Too good to be true. Can’t believe I was able to get more shares at this discounted price. Gray skies are gonna clear up. More and more contracts being signed more sales force just hired this is gonna rebound very nicely heading into rest of the week
Big story wow a real purchase order to refute the purported slam saying never heard of nexcf. Proof positive. Don’t let the false spewing short take your shares. This stock is gonna climb the highest mountain. Waiting to hear Evan on a buying spree with multiple millions of purchasing power waiting to be used.
Just think how brilliant this release is. It’s phase one for safety which we already knew would be spectacular smoking the current SOC. It’s like putting out an appetizer. Shorts and AF understandably would manipulate and not read full report and cherry pick saying efficacy not released because results are bad. Stock grinds lower and longs thank them for picking up cheaper shares. Now shareholders meeting tomorrow for approval of 100,000,000 shares which maybe 20% needed to continue many trials and cash for uplisting and to stave off hostile takeover. Tonight DrDrew and Dr. Yo having a nice conversation about trial results. Now the meal is being prepared as efficacy comes out toward end of week hopefully right b4 close on Friday trapping all shorts heading into weekend. Then for dessert next week interim safety committee results and approval as new SOC for Covid. What a delicious way to feast as price tips higher and shorts only get the scraps. Bankrupt
I just got really bad news. This stock is gonna put me in a higher tax bracket. Lol let’s get these fantastic results and get approvals and start saving people’s lives.
Welcome don’t let detractors shade you from the truth. Covid -19 has changed the game for AR/VR. In this new world we are experiencing many changes that take a little while to get used to. Like learning to ride a bike, training wheels are in right now. Once the word gets out, and Android and IOS downloads commence, this is gonna fly. Retailers have no business as stores are shuttered. They will rely on the best platform to sell their goods. Telemedicine is huge as no one wants to go to a doctors office. Businesses and schools allarounfythe world will open on a modified schedule with remote learning becoming ever more prevalent. Today is just a minor blip and a reason to get shares on the cheap.
Much news to come this week. Healthy pullback. I’m sure there will be numerous short attacks this week that the weak hands folded their shares. Shake the tree and move on from here. Many different innovations on the horizon and with the world locked down there will be many who will rely on our platform. This stock has legs to grow and the potential upside is tremendous.
Undeniably this stock had a very strong run up on news that it will be a game changing stock with tremendous growth in the near future and beyond. With this it’s expected that there will be profit taking which is a smart move. The bs hit pieces and shorts combined with some profit taking and sheep’s got slaughter who got in at the top fled this stock. Inexperienced traders looking to ride the momentum. Once this fills in bottom already reached and now we slowly run higher awaiting uplifting and continued growth as we expand with revolutionary technologies and platforms. Growth next quarter will be huge and revenues to follow. Not giving up my shares and will continue buying on the dips. GLTA
After weekend hit pieces and and badgers looking to get in on this gem at a bargain, I am very happy to grab more here at a discount. Appreciate the good work by shorts allowing us to grab gold without having to use dynamite and pickaxes.
Small blip today. This company puts out tons of pr to let shareholders see contracts being signed on a daily basis and the uses of their products growing through multiple platforms. The escalator started in the basement and now we are just making it to the first floor of a 20 story building hence the $40 million in revenue projections which will get here even more quickly due to the pandemic. All retailers, schools, businesses are looking to the future with AR/ VR being used to get their products into shoppers houses and businesses. Seeds have been planted and once the hired sales help begins aggressively marketing and selling platform with $100k a month per salesperson x 3 this will increase revenues rapidly.
Wow looks like a lot riding on results. If you hear Dr. BP and Dr Yo and all the doctors who have been part of study from Montefiore and UCLA and hear the testimonials of Samantha Moffet and others, there is no way to think that Leronlimab will fail in 1) It’s safety 2) It’s results. So it appears way more than a 50/50 bet that many are putting on the results. However the doubts remain about FDA and big pharma and their army of lobbyists and swamp rats that only care about their survival and bottom line. What a twisted world to be in. After excellent unblinding results, I am hopeful that we are able to complete uplist, raise shares to prevent buyout, and move forward on the BLA.
So far there have been numerous reports of BP having success in their trials and the tv pundits and news reporters salivating over any news having to do with promises of a vaccine. But how effective will they be and how safe. Money being thrown around during operation WarpSpeed without even knowing if things will pan out. Leronlimab results will come out in the next two weeks or so and we all are hoping for stellar results and can’t wait to finally start saving lives, the economy, and society not living in fear of catching the virus.
Big bounce coming knee jerk reaction to news this morning. It is not a death sentence only purgatory. Once needed info is disseminated and trial results are known prepare for that ride up the mountain. We are in really good shape and looking to add before conference call.
The roller coaster ride goin up was extremely exciting, however the fall is precipitous. The stock will plunge early but there is room for hope by end of day. Ten percent down has been the going rate but can expect a minus five added to that. Stay long and stay strong. We know that bombs can be dropped and after dust settles we are still building momentum towards a better tomorrow. Have faith and we will persevere.
Refuse to file. Great start to the week. Let’s hope theFDA allows schedule A meeting if not this stock has to rely on trial results which better be great. A lot of promises seem to be rhetoric at this time. The new positions posted on web better be filled by competent and knowledgeable people who can follow through with CYDY vision of getting approvals across the finish line. Heavy short pressure expected this week.